Access delayed - the stakes are high for the industry's next agreements

The current agreement between the Commonwealth and the research-based pharmaceutical industry promised faster access to new medicines through HTA reforms. Four years on, that reform is still unfinished. In the first of two articles, Jody Fassina of Insight Strategy asks what was promised, what was delivered and who pays while patients wait. …